Demegestone

DB13857ExperimentalSmall molecule

Demegestone is a progesterone receptor agonist that was previously used to treat luteal insufficiency. It was previously marketed in France as Lutionex, but has since been discontinued.

Chemical structure of Demegestone
Mechanism
Curator reviewed
Formula / weight
C21H28O2 · 312.4458 g/mol (avg)
Code names
R 2453

Resolves to

Compound
UNII6E89AM91SZCAS10116-22-0ChEMBLCHEMBL2104231ChEBI135339KEGGD07223
Clinical / RWD
RxNorm22483ATCG03DB05
Structure
InChIKeyJWAHBTQSSMYISL-MHTWAQMVSA-NSMILES[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H]
Targets
P06401PGR

What you can answer from here — as of February 21, 2021

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
544Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 18 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Demegestone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In